Pharmaceuticals

Pharmaceutical company Incyte will pay $12.6 million to resolve allegations it violated the False Claims Act, the Justice Department announced Tuesday, adding that there has been no determination of liability. The company was accused of using an independent foundation to pay copays of certain people taking its drug Jakafi, which has been approved to treat a type of bone marrow cancer.

Read more

Whistleblower Retaliation

The Sixth Circuit reinstated a doctor’s claim he was fired for reporting that his employer was paying kickbacks to physicians for referring Medicare and Medicaid patients. The False Claims Act’s retaliation clause can be applied to an employer’s actions after it fires an employee. To read the law otherwise would encourage employers to harass and threaten whistleblowers so long as they fire them first.

Read more

Ousted US Vaccine Chief Preps Whistleblower Claims Over Trump-Touted Drug

Attorneys for Rick Bright, the former head of a key U.S. agency spearheading vaccine development in response to the novel coronavirus pandemic, announced Thursday that their claims of a White House campaign to oust their client for resisting political pressure and cronyism will be revealed in a whistleblower complaint.

Read more